The Centers for Disease Control and Prevention (CDC) announced today that the recommendation for use of Prevnar®, Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein), has been updated, reinstating the full, four-dose vaccination schedule.Prevnar, the first and only vaccine available to help prevent invasive pneumococcal disease (IPD) in both infants and young children, is approved to be given in a four-dose series to healthy children at 2, 4, 6 and 12 to15 months of age. However, a shortage of vaccine earlier this year prompted the CDC to modify their recommendations for administration to healthy children. The CDC recommends that providers resume administration of the vaccine according to the routine schedule.
